Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts

Transplant Proc. 1996 Jun;28(3):1591-3.

Authors

K Hoshinaga¹, R Shiroki, T Higuchi, Y Horiba, M Yanaoka, Y Naide

Affiliation

¹ Department of Urology, Fujita Health University, School of Medicine, Aichi, Japan.

PMID: 8658798

No abstract available

Publication types

Comparative Study

MeSH terms

Adolescent
Adult
Antilymphocyte Serum / therapeutic use
Azathioprine / therapeutic use*
Cadaver
Creatinine / blood
Cyclosporine / therapeutic use*
Drug Therapy, Combination
Follow-Up Studies
Graft Survival*
Heart Arrest
Humans
Immunosuppressive Agents / therapeutic use*
Kidney Transplantation / immunology*
Kidney Transplantation / mortality
Kidney Transplantation / physiology
Methylprednisolone / therapeutic use*
Middle Aged
Ribonucleosides / therapeutic use*
Survival Rate
Tissue Donors

Substances

Antilymphocyte Serum
Immunosuppressive Agents
Ribonucleosides
mizoribine
Cyclosporine
Creatinine
Azathioprine
Methylprednisolone